C-CAR031

BIOLOGICAL2 trials

Sponsors

Zhejiang University, Shanghai AbelZeta Ltd.

Conditions

Hepatocellular CarcinomaSquamous Cell Lung Cancer

Phase 1

A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma

RecruitingNCT05155189

Zhejiang UniversityHepatocellular Carcinoma

Start: 2022-02-21End: 2041-05-01Target: 72Updated: 2026-01-21

An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer

RecruitingNCT07444281

Shanghai AbelZeta Ltd.Squamous Cell Lung Cancer

Start: 2024-12-25End: 2028-01-30Target: 24Updated: 2026-03-03

Related Papers

Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC).

Journal of Clinical Oncology2024-06-0139 citations